Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Edwards Lifesciences Corp | ex-991pressrelease.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) October 22, 2015
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 1-15525 | 36-4316614 | ||
(State or other jurisdiction of incorporation) | (Commission file number) | (IRS Employer Identification No.) | ||
One Edwards Way, Irvine, California | 92614 | |
(Address of principal executive offices) | (Zip Code) | |
(949) 250-2500 |
Registrant’s telephone number, including area code |
N/A |
(Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-Commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-Commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(d) On October 23, 2015, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Martha H. Marsh was appointed to the Company’s Board of Directors. The appointment was effective on October 22, 2015.
There is no arrangement or understanding between Ms. Marsh and any other persons pursuant to which she was selected as a director. Ms. Marsh has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Ms. Marsh will receive the same compensation and agreements as the Company’s other nonemployee directors as described in the Company’s 2015 Proxy Statement.
A copy of the press release announcing her appointment is filed as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
99.1 | Press Release dated October 23, 2015 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: October 23, 2015
EDWARDS LIFESCIENCES CORPORATION | |||||
By: | /s/ Denise E. Botticelli | ||||
Denise E. Botticelli | |||||
Vice President, Associate General Counsel, and Secretary | |||||
Exhibit Index
Exhibit Number | Description | |
99.1 | Press Release dated October 23, 2015 | |